Your browser doesn't support javascript.
loading
Tolvaptan in portal hypertension: real life experience.
Tejedor, Marta; Delgado, Agustín; Melero, Rosa; Fernández-Alonso, Víctor; Salcedo, Magdalena; Rodríguez-Benítez, Patrocinio.
Afiliação
  • Tejedor M; Hepatology, Hospital Universitario Infanta Elena, España.
  • Delgado A; Medicine, Universidad Complutense de Madrid, Spain.
  • Melero R; Nephrology, Hospital General Universitario Gregorio Marañón, Spain.
  • Fernández-Alonso V; Hepatology and Liver Transplantation Unit, Hospital General Universitario Gregorio Marañón, Spain.
  • Salcedo M; Hepatology and Liver Transplantation Unit, Hospital General Universitario Gregorio Marañón, Spain.
  • Rodríguez-Benítez P; Nephrology, Hospital General Universitario Gregorio Marañón, Spain.
Rev Esp Enferm Dig ; 115(4): 206, 2023 04.
Article em En | MEDLINE | ID: mdl-36093979
Tolvaptan (TVP) is a selective antagonist of vasopressin receptors, approved for the treatment of hyponatremia in SIADH, congestive heart failure (CHF) and cirrhosis. We retrospectively reviewed all cases where TVP was used in a tertiary hospital (January 2012- January 2017). Our aim was to study the use of TVP in real life practice in patients with portal hypertension (PHT) (past history of non-malignant ascites or variceal bleed).
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipertensão Portal / Hiponatremia Limite: Humans Idioma: En Revista: Rev Esp Enferm Dig Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipertensão Portal / Hiponatremia Limite: Humans Idioma: En Revista: Rev Esp Enferm Dig Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article